MedPath

Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) - Assay

Not Applicable
Completed
Conditions
Sunscreen Agents
Interventions
Drug: BAY 987516
Drug: SPF 15 Control
Registration Number
NCT02872246
Lead Sponsor
Bayer
Brief Summary

Evaluation of the effectiveness of a sunscreen product by determining its Sun Protection Factor (SPF) on the skin of human subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • Male or female of an age of 18 to 70 years inclusive;
  • Fitzpatrick Skin Type I, II and/or III for SPF testing;
  • Good health as determined from the CRO Subject History Form (SHF);
  • Signed and dated Informed Consent Form;
  • Signed and dated Health Insurance Portability and Accountability Act (HIPAA) Form;
  • An unambiguous minimal erythema dose (MED).
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SPF evaluationBAY 987516Subjects with good health as determined from the CRO Subject History Form (SHF) and Fitzpatrick Skin Type I, II and/or III were included for SPF testing.
SPF evaluationSPF 15 ControlSubjects with good health as determined from the CRO Subject History Form (SHF) and Fitzpatrick Skin Type I, II and/or III were included for SPF testing.
Primary Outcome Measures
NameTimeMethod
Evaluation of water resistant SPF16-24 hours post exposure

For the sunscreen Test Material, two test sites were used; one for before immersion and one for after 2 hours of water immersion. One additional test site area was used for the control SPF determination, on each subject, as per the COLIPA Sun Protection Factor Test Method.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath